A long-term non-interventional study to assess the incidence of skin malignancies in patients with dystrophic and junctional epidermolysis bullosa receiving treatment with Filsuvez (FOSTER)

05/07/2024
02/07/2025
EU PAS number:
EUPAS1000000244
Study
Planned
Documents
Study protocol
Initial protocol
English (1.26 MB - PDF) View document
Study results
Study report
Other information